Dashboard
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 2.82 times
Healthy long term growth as Net Sales has grown by an annual rate of 12.86%
The company has declared Positive results for the last 5 consecutive quarters
With ROCE of 8.55%, it has a fair valuation with a 1.58 Enterprise value to Capital Employed
High Institutional Holdings at 100%
Market Beating performance in long term as well as near term
Total Returns (Price + Dividend) 
MKS Instruments, Inc. for the last several years.
Risk Adjusted Returns v/s 
News

MKS Instruments, Inc. Experiences Valuation Adjustment Amid Strong Market Performance
MKS Instruments, Inc. has recently adjusted its valuation, with its stock price rising to $143.71. Over the past year, the company has achieved a 44.68% return, outperforming the S&P 500. Key financial metrics indicate solid operational performance, positioning MKS favorably among its industrial manufacturing peers.
Read MoreIs MKS Instruments, Inc. overvalued or undervalued?
As of 24 October 2025, the valuation grade for MKS Instruments, Inc. has moved from attractive to fair, indicating a shift in its perceived value. The company appears fairly valued based on its current metrics. Key ratios include a P/E ratio of 19, an EV to EBITDA of 11.18, and a PEG ratio of 0.30, which suggests that the stock is reasonably priced relative to its growth potential. In comparison to peers, MKS Instruments, Inc. has a lower P/E ratio than Woodward, Inc., which stands at 42.20, and is also more favorable than Graco, Inc. at 29.51. This positions MKS competitively within the industrial manufacturing sector. Notably, MKS has outperformed the S&P 500 over various periods, with a year-to-date return of 36.93% compared to the S&P 500's 15.47%, reinforcing the notion that the stock is performing well despite its current fair valuation....
Read More
MKS Instruments Hits New 52-Week High of $146.72, Showcasing Strong Growth
MKS Instruments, Inc. has achieved a new 52-week high, reflecting strong performance with a 43.83% return over the past year. The company boasts a market capitalization of USD 7,322 million, a solid financial foundation, and impressive growth in net sales, alongside a healthy debt profile and high institutional holdings.
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 116 Schemes (57.44%)
Held by 174 Foreign Institutions (15.43%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is 3.95% vs 0.11% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is 19.23% vs -42.22% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -0.99% vs 2.11% in Dec 2023
YoY Growth in year ended Dec 2024 is 110.32% vs -652.85% in Dec 2023






